Literature DB >> 29306815

Chondroitin sulfate-stabilized silver nanoparticles: Improved synthesis and their catalytic, antimicrobial, and biocompatible activities.

Jenn-Jong Young1, Kuang-Ming Cheng1, Yen-An Young2, Xin-An Chen1, Yu-Hao Chen1, Tein-Yao Chang1, Hui-Ju Yen3, Cheng-Cheung Chen4.   

Abstract

Herein, we describe an improved procedure for the green synthesis of chondroitin sulfate stabilized silver nanoparticles (ChS-AgNPs). Glucose was used as a reducing agent under alkaline conditions to obtain a small particle size (<10 nm), and the reduction was complete within one hour at room temperature. The concentration of NaOH affected the reaction rate, formation yield, and particle size of ChS-AgNPs. The formation of AgNPs was confirmed using UV-vis, TEM, XRD, and XPS. ChS-AgNPs showed excellent catalytic activities in the reduction of 4-nitrophenol by NaBH4, and the reaction rate increased linearly with increasing catalyst amounts. The antimicrobial activities of ChS-AgNPs against A. baumannii (including multidrug-resistant strains), E. coli, P. aeruginosa, and S. aureus were evaluated using the broth microdilution method. Finally, from the morphological observations and cell cycle analysis of L929 cells, we found that ChS-AgNPs exhibited antimicrobial and biocompatible activities.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Antimicrobial and biocompatible activities; Catalytic activity; Chondroitin sulfate; Green synthesis; Multidrug-resistant Acinetobacter baumannii; Silver nanoparticles

Mesh:

Substances:

Year:  2017        PMID: 29306815     DOI: 10.1016/j.carres.2017.12.004

Source DB:  PubMed          Journal:  Carbohydr Res        ISSN: 0008-6215            Impact factor:   2.104


  1 in total

1.  Alginate-Capped Silver Nanoparticles as a Potent Anti-mycobacterial Agent Against Mycobacterium tuberculosis.

Authors:  Cheng-Cheung Chen; Yih-Yuan Chen; Chang-Ching Yeh; Chia-Wei Hsu; Shang-Jie Yu; Chih-Hao Hsu; Ting-Chun Wei; Sin-Ni Ho; Pei-Chu Tsai; Yung-Deng Song; Hui-Ju Yen; Xin-An Chen; Jenn-Jong Young; Chuan-Chung Chuang; Horng-Yunn Dou
Journal:  Front Pharmacol       Date:  2021-11-17       Impact factor: 5.810

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.